A team of scientists at the University of Toronto has discovered the mechanism linking periodontal disease to other inflammatory conditions. The study found that neutrophil immune cell activity is the key factor connecting gum disease to heart disease, cancer, and other inflammatory conditions.
A collaboration between University of Toronto and National Jewish Health has yielded a new drug discovery that could combat inflammation and acute respiratory illnesses like COVID-19. The 'drug' is a combination of two naturally occurring peptides, TAT CARMIL1, which reduces collagen degradation by up to 43%.
A University of Toronto team has been awarded a $1.5 million grant to study the impact of cannabis use on Indigenous oral health in Canada. The study will gather first evidence of the effects of cannabis on Indigenous populations, working in partnership with communities and public health authorities.
Researchers at the University of Toronto have discovered two distinct neutrophil states in blood, which vary depending on patient health and infection status. These findings may lead to new models for disease detection and monitoring, such as tracking primed neutrophils to predict inflammatory diseases.
A significant rise in oral cancer and pre-cancerous lesion detection by dentists in Ontario is reported, with a nearly doubling of cancers detected between 2005 and 2015. The study suggests that comprehensive training and continuing education programs for oral health professionals may be behind the dramatic increase in detection rates.
Researchers at the University of Toronto found that an abnormal immune response between neutrophils and cancer cells drives oral cancer metastasis. This connection may lead to targeted immunotherapies to shut down the abnormal response.
Researchers discover TMPRSS2 gene as key player in triggering severe forms of cancer pain. The discovery could lead to targeted therapies shutting down the expression of this gene or its ability to infiltrate pain receptors.
Researchers at the University of Toronto's Faculty of Dentistry have identified Adseverin as a key driver behind bone loss associated with periodontitis and other inflammatory diseases. The protein plays a critical role in generating larger osteoclasts, leading to rapid bone loss.